Retrospective single-centre study investigating impact of prophylaxis with posaconazole and levofloxacin in acute myeloid leukemia patients undergoing intensive chemotherapy

Trial Profile

Retrospective single-centre study investigating impact of prophylaxis with posaconazole and levofloxacin in acute myeloid leukemia patients undergoing intensive chemotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Dec 2015

At a glance

  • Drugs Levofloxacin (Primary) ; Posaconazole (Primary) ; Amphotericin B; Cefepime; Dexamethasone; Piperacillin/tazobactam; Sulfamethoxazole; Trimethoprim
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top